Text Only Version A | A | A

New HFEA data highlight fertility inequalities for Black, Asian and minority ethnic patients

Responding to the new report from the HFEA, Marta Jansa Perez, Director of Embryology at BPAS, said:

“This new report from the HFEA uncovers the scale of inequalities faced by Black, Asian and minority ethnic fertility patients. The disadvantages faced by Black patients in particular are striking: they have the lowest chance of a successful treatment and are also less likely than Asian or White patients to have their treatment funded by the NHS. The report also highlights the struggles that minority ethnic patients face when using donor eggs. Because of the fact that 89% of egg donors are White, in more than half of cycles with an Asian egg recipient, eggs from White donors are used.

“We welcome this important report from the HFEA, and we must work to ensure it is the beginning of a larger process of data collection and research, to promote equal access to fertility services. BPAS Fertility echoes the HFEA’s recommendations and would like to encourage commissioners across the UK to review their funding eligibility criteria, in order to consider whether their policies have an adverse impact on treatment access for particular ethnic groups.”

ENDS

For more information, please email press@bpas.org or call 07881 265276.

About BPAS

BPAS is a charity that sees almost 100,000 women a year for reproductive healthcare services including pregnancy counselling, abortion care, miscarriage management and contraception, at clinics across the UK. It supports and advocates for reproductive choice.

BPAS also runs the Centre for Reproductive Research and Communication, which seeks to develop and deliver a research agenda that furthers women’s access to evidence-based reproductive healthcare, driven by an understanding of women’s perspectives and needs. You can find out more here.

BPAS intends to launch a not-for-profit fertility service in Autumn 2021, to provide ethical, evidence-based, person-centred care that supports patients. We intend to only charge what it costs to provide a safe, high-quality, and accessible service to patients who may be unable to access NHS-funded care.